Cargando…
The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis
BACKGROUND: Interferon-beta (IFN-beta) is a commonly used treatment for multiple sclerosis (MS). Current guidelines recommend cessation of treatment during pregnancy, however the results of past studies on the safety of prenatal exposure to IFN-beta have been conflicting. A large scale study of a po...
Autores principales: | Burkill, Sarah, Vattulainen, Pia, Geissbuehler, Yvonne, Sabido Espin, Meritxell, Popescu, Catrinel, Suzart-Woischnik, Kiliana, Hillert, Jan, Artama, Miia, Verkkoniemi-Ahola, Auli, Myhr, Kjell-Morten, Cnattingius, Sven, Korhonen, Pasi, Montgomery, Scott, Bahmanyar, Shahram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936848/ https://www.ncbi.nlm.nih.gov/pubmed/31887199 http://dx.doi.org/10.1371/journal.pone.0227120 |
Ejemplares similares
-
Pregnancy outcomes after exposure to interferon beta: a
register-based cohort study among women with MS in Finland and
Sweden
por: Hakkarainen, Katja Marja, et al.
Publicado: (2020) -
Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry
por: Hellwig, Kerstin, et al.
Publicado: (2020) -
Multiple sclerosis and risk of young-adult-onset Hodgkin lymphoma
por: Montgomery, Scott, et al.
Publicado: (2016) -
Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients
por: Hajiebrahimi, Mohammadhossein, et al.
Publicado: (2016) -
Progressive Multifocal Leukoencephalopathy: Current Insights
por: Kartau, Marge, et al.
Publicado: (2019)